Pharvaris officer plans $1.06M stock sale

An officer of Pharvaris N.V. has filed a Rule 144 notice to sell 30,000 common shares obtained through stock option exercises.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) has an officer, Peng Lu, who has filed a notice of proposed sale of common shares under Rule 144. The notice covers 30,000 common shares, to be obtained through the exercise of stock options for cash on or about September 8, 2026.

The shares listed for potential sale have an aggregate market value of $1,057,500, and the notice references 68,072,885 common shares outstanding. The officer also reports prior Rule 10b5-1 plan sales of Pharvaris common stock in the past three months.

Key Figures

Shares to be sold: 30,000 shares of common stock Aggregate market value of proposed sale: $1,057,500 Shares outstanding: 68,072,885 shares +3 more

6 metrics

Shares to be sold 30,000 shares of common stock Proposed Rule 144 sale by an officer, expected around September 8, 2026

Aggregate market value of proposed sale $1,057,500 Value attributed to 30,000 Pharvaris common shares covered by the notice

Shares outstanding 68,072,885 shares Pharvaris common shares reported outstanding in the notice

Sale on June 18, 2026 300 shares for $10,200.00 Rule 10b5-1 sale of Pharvaris common stock by Peng Lu

Sale on June 25, 2026 15,000 shares for $518,985.00 Rule 10b5-1 sale of Pharvaris common stock by Peng Lu

Sale on June 26, 2026 14,700 shares for $499,847.04 Rule 10b5-1 sale of Pharvaris common stock by Peng Lu

Key Terms

Rule 144, 10b5-1, Exercise of Stock Options, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 regulatory

"10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Common | 09/08/2026 | Exercise of Stock Options | Issuer"

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC Executive Financial Services ... | 30000 | 1057500.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing indicate for Pharvaris N.V. (PHVS)?

The Form 144 notice states that an officer of Pharvaris N.V., Peng Lu, intends to sell 30,000 common shares of Pharvaris, to be acquired through the exercise of stock options for cash around September 8, 2026, under Rule 144.

How many Pharvaris (PHVS) shares are planned to be sold under this Form 144?

The notice covers a proposed sale of 30,000 Pharvaris common shares. These shares are expected to be received upon the exercise of stock options, with the exercise and sale dates serving as the dates of acquisition and payment.

What is the aggregate market value of the Pharvaris (PHVS) shares in the planned Rule 144 sale?

The Form 144 lists an aggregate market value of $1,057,500 for the 30,000 Pharvaris common shares covered by the planned sale. This value is based on market pricing at the time of the notice.

How many Pharvaris (PHVS) shares are reported as outstanding in the Form 144?

The notice reports that Pharvaris has 68,072,885 common shares outstanding. This figure is given as context for the Rule 144 sale and is separate from the 30,000 shares covered by the proposed transaction.

What prior sales by the officer are disclosed in the Pharvaris (PHVS) Form 144?

The filing lists prior Rule 10b5-1 sales of Pharvaris common stock by Peng Lu: sales on June 18, 2026, June 25, 2026, and June 26, 2026, with reported proceeds of $10,200.00, $518,985.00, and $499,847.04, respectively.

How will the Pharvaris (PHVS) officer receive the shares to be sold under Rule 144?

The notice explains that the securities to be sold were and will be received upon the exercise of stock options over the next three months. It states that the dates of acquisition and payment were and will be the dates of exercise and sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:24 PM Accepted by SEC EDGAR 09/08/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001972159
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pharvaris N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	310712036410
Name of Person for Whose Account the Securities are To Be Sold	PENG LU
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30000	1057500.00	68072885	09/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/08/2026	Exercise of Stock Options	Issuer			30000	09/08/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/26/2026	14700	499847.04
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/25/2026	15000	518985.00
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/18/2026	300	10200.00

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	09/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peng Lu
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)